Xilio Therapeutics, Inc.

XLO

—

Advanced chart & tools →

Xilio Therapeutics, Inc.XLO

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-4.19

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$43.77M

Net income

$-35.04M

Net margin

-80.1%

Gross margin

—

Dividends & financials

Xilio Therapeutics, Inc. (XLO) reported revenue of $43.77M and net income of $-35.04M, or $-4.19 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.